
Keywords: سرم آمیلوئید P; ACEi; Angiotensin converting enzyme inhibitors; ESRD; end stage renal disease; eGFR; estimated glomerular filtration rates; FLC; free light chain; PAS; periodic acid Schiff; RAAS; renin-angiotensin-aldosterone; SAP; serum amyloid P;